Chiasma is conducting another clinical trial for Acromegaly patients, the MPOWERED study.
“It is designed to compare the safety and effectiveness of an investigational new drug product, octreotide capsules, to injectable octreotide and lanreotide in patients with acromegaly”
About 150 participants are needed for this study and there is no cost to participate. If you are a U.S. resident between age 18 and 75 with an acromegaly diagnosis you may be eligible to participate.
The study will consist of 3 parts; a 26 week period, a 36 week period, and then a study extension period.